4/25/25 16:32 | 4/25/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Woteki Catherine E | MI | D | | 1 | P | 30 | 5.17 | 0 | 6 | 77 | 13 | D | | | | | | | | | | | | | | |
4/25/25 14:45 | 4/24/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | MI | D | | 2 | P | 321 | 4.94 | 0 | 65 | 255 | 90 | D | | | | | | | | | | | | | | |
4/24/25 15:34 | 4/24/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | MI | D | | 1 | P | 26 | 5.24 | 0 | 5 | 16 | 36 | D | | | | | | | | | | | | | | |
4/23/25 10:46 | 4/23/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rocklin Amy M | MI | O | GC | 1 | P | 62 | 4.99 | 0 | 13 | 53 | 36 | D | | | | | | | | | | | | | | |
4/22/25 15:37 | 4/22/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Capello Jeffrey D | MI | D | | 1 | P | 100 | 4.84 | 0 | 21 | 350 | 27 | D | | | | | | | | | | | | | | |
4/22/25 11:46 | 4/22/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | 1 | P | 47 | 4.73 | 0 | 10 | 36 | 37 | D | | | | | | | | | | | | | | |
4/22/25 11:43 | 4/22/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rodriguez Rafael A | MI | D | | 1 | P | 34 | 4.59 | 0 | 7 | 100 | 15 | D | | | | | | | | | | | | | | |
4/10/25 10:12 | 4/10/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Moylan John Patrick | MI | O | Chief Ac | 1 | P | 51 | 5.07 | 0 | 10 | | 10 | D | | | | | | | | | | | | | | |
3/27/25 08:13 | 3/26/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | 1 | P | 100 | 0.5500 | 0 | 182 | 6 | 3,341 | D | | | | | | | | | | | | | | |
3/27/25 08:13 | 3/26/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | 1 | P | 100 | 0.5500 | 0 | 182 | 6 | 3,243 | D | | | | | | | | | | | | | | |
3/19/25 16:38 | 3/17/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Oki Mark K | WA | O | CFO | 1 | P | 29 | 2.89 | 0 | 10 | | 10 | D | | | | | | | | | | | | | | |
3/19/25 16:32 | 3/17/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Chieve E | 1 | P | 29 | 2.86 | 0 | 10 | 19 | 62 | D | | | | | | | | | | | | | | |
2/11/25 19:00 | 2/7/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | 1 | P | 200 | 2.05 | 0 | 98 | 182 | 151 | D | | | | | | | | | | | | | | |
2/11/25 17:00 | 2/7/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T | | 2 | P.m | 2,211 | 2.05 | 0 | 1,079 | 49 | 3,258 | I | | | | | | | | | | | | | | |
2/10/25 20:43 | 2/6/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | 1 | P.d | 10,590 | 2.05 | 0 | 5,166 | 29 | 22,820 | M | | | | | | | | | | | | | | |